A “New” Kind of Classic Coke: Why Coca-Cola Company (NYSE:KO) Could Send Aurora Cannabis Inc. (TSX:ACB) Blazing Past All-time Highs

Coca-Cola Company (NYSE:KO) could give Aurora Cannabis (TSX:ACB) a boost to $20 if a deal is struck.

| More on:

I, along with many other Fools, have been pounding the table on Aurora Cannabis (TSX:ACB) stock over the past few months at a time when it lagged the broader basket of marijuana stocks. When compared side-by-side to the likes of Canopy Growth (TSX:WEED)(NYSE:CGC) or Tilray, Aurora sure looked like a complete dud of a trade.

But when you consider the fact that today’s hottest pot stocks already have the most predictable positive developments in the rear-view mirror, one has to think that Aurora has substantially more upside than anything else in the industry.

Well-established behemoths across various industries (alcohol, tobacco, pharmaceuticals, and consumer packaged goods) are likely itching to get a puff out of marijuana to spark a new wave of growth that many of us have never seen.

You’ve probably heard enough about Constellation Brands and its upped investment in Canopy. It’s been the talk of the town, and the development has been rocket fuel for Canopy stock.

As I’ve mentioned in many previous pieces, investors should be looking to where the puck’s going to be next, not where it’s at right now. Aurora is where I believe the puck is headed next and its “serious talks” with Coca-Cola Company (NYSE:KO) could mark the start of a rally that could bring the company back in the race with its biggest rival: Canopy Growth.

Not your classic Coke!

Aurora shares soared nearly 17% in a single trading session on news of Coca-Cola’s interest in teaming up to develop a CBD-infused “recovery” beverage.

Before you get too excited about the thought of getting high off Warren Buffett’s favourite beverage, you should know that CBD (cannabidiol) isn’t the cannabis constituent that gets you high. That’s another compound called THC (tetrahydrocannabinol), and unfortunately for recreational stoners, there have yet to be reports of Coca-Cola’s interest in producing a THC-infused version of Coke.

CBD is a non-psychoactive compound derived from cannabis that’s been known to play a role in the easing pain and inflammation. The potential medicinal applications are remarkable, and while the public may be more focused on THC, I believe we’ll begin to see more buzz concerning other cannabinoids, especially among firms that are focused on the medicinal side of weed.

According to a projection from a report issued by the Hemp Business Journal, the CBD consumer market is projected to grow to US$2.1 billion by 2020. That’s a pretty big market, and while everybody has been focusing on THC, Aurora has stealthily grabbed a front-row seat to the explosive and underrated CBD market with its Hempco Food and Fiber acquisition, which is a perfect fit alongside Aurora’s other medical-focused pot assets.

So, what’s next?

Expect Coca-Cola to sign on the dotted line at some point over the next few weeks.

I think Coca-Cola may be looking to dip its toe in the cannabis waters in the same way that Constellation Brands did, but unlike Constellation, I don’t think Coca-Cola is going to open up its chequebook when it comes to investing Aurora.

Instead, I believe that Coca-Cola is going to create a long-term supply relationship with Aurora, and if the future CBD-infused beverage shows promise (they likely will), Coca-Cola is probably going to double down on cannabis infusion by going for a THC-infused beverage next and a line of THC/CBD hybrid drinks of varying ratios.

While Coca-Cola may be up for a small stake in the future, I don’t think such an investment would make sense given Aurora’s in the business of medicinal cannabis, and would likely be a more compelling target for a pharmaceutical giant looking for a hedge.

Foolish takeaway

The Coca-Cola/Aurora talks are promising. I think a joint venture is going to be announced soon with further supply deals at some point down the road.

While many Coca-Cola fans think that a jump into cannabis could hurt the brand’s image, I think the firm’s pot expedition will do profoundly more good than harm for sales, especially when you consider the fact that Coca-Cola was originally a medicinal beverage derived from Coca leaves, a raw material used in the manufacture of cocaine! After all these decades, Coca-Cola is becoming a medicinal beverage again!

I’d buy both Coke and Aurora, right here.

Stay hungry. Stay Foolish.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Investing

Investor reading the newspaper
Dividend Stocks

BCE’s Dividend Has Been Getting a Lot of Attention: Here’s Why

Long-term investors could investigate BCE as an income play with multi-year turnaround potential.

Read more »

data analyze research
Dividend Stocks

TFSA at 60: 2 Dividend Stocks to Help Any Canadian Catch Up

Build a stronger TFSA at 60 with two dependable Canadian dividend stocks offering income, stability, and long-term growth potential.

Read more »

bank of canada governor tiff macklem
Bank Stocks

The Bank of Canada Just Spoke: 2 Canadian Stocks I’d Buy Before Rates Fall Further

With Canadians carrying $1.80 of debt for every after-tax dollar earned, interest rates could shape both borrowers and TSX returns.

Read more »

senior man and woman stretch their legs on yoga mats outside
Retirement

Reaching Retirement: Here’s the Typical TFSA Balance for Canadians Approaching 60

You can build a substantial TFSA as a part of your retirement planning strategy. Start by maximizing your TFSA contributions.

Read more »

man touches brain to show a good idea
Dividend Stocks

2 Dividend Stocks That Look Built for the Rate Pause

These high-quality dividend stocks offer attractive yields, dependable income, and protection against inflation.

Read more »

dividends grow over time
Dividend Stocks

A Value Stock With a Dividend Yield Over 6% to Buy Near 52-Week Lows

Explore the current landscape of dividend stocks and why they are influenced by rising interest rates and financial leverage.

Read more »

people relax on mountain ledge
Dividend Stocks

How to Use Your TFSA to Average $1,500 per Year in Tax-Free Passive Income

These two Canadian dividend stocks could boost your passive income.

Read more »

drinker sniffs wine in a glass
Energy Stocks

What the Average Canadian TFSA Balance Looks Like at 70

Many Canadians reach 70 with a solid TFSA balance. The next step is choosing investments that can keep delivering income…

Read more »